SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-036367
Filing Date
2024-02-14
Accepted
2024-02-14 16:36:10
Documents
2
Group Members
BELLCO LEGACY IV, LLCBELLCO LEGACY LLCVIDA VENTURES LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d751841dsc13ga.htm SC 13G/A 87795
2 EX-99.1 d751841dex991.htm EX-99.1 5906
  Complete submission text file 0001193125-24-036367.txt   95170
Mailing Address UCLA SCHOOL OF MEDICINE 10833 LE CONTE 66-118 CHS BOX 951738 LOS ANGELES CA 9095-1738
Business Address
Belldegrun Arie (Filed by) CIK: 0001296549 (see all company filings)

Type: SC 13G/A

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90685 | Film No.: 24639346
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)